Page last updated: 2024-10-28

lidocaine and Carcinoid Tumor

lidocaine has been researched along with Carcinoid Tumor in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jabbour-Khoury, S1
Dabbous, A1
al-Jazzar, M1
Rizk, M1
Chahine, M1
Khalife, M1
Ayoub, C1
Baraka, A1

Other Studies

1 other study available for lidocaine and Carcinoid Tumor

ArticleYear
Anesthetic management of a patient having a carcinoid syndrome.
    Middle East journal of anaesthesiology, 2003, Volume: 17, Issue:3

    Topics: Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Atracurium; Carcinoid Tumor; Fema

2003